Here, we provide molecular and functional evidence of major changes in neuronal energy metabolism in CHMP2B mediated Frontotemporal Dementia (FTD3) using patient-derived iPSC disease models. The gene discussed is CHMP2B; the disease is frontotemporal dementia.